These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 24213248

  • 1. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
    Meloni BP, Craig AJ, Milech N, Hopkins RM, Watt PM, Knuckey NW.
    Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
    [Abstract] [Full Text] [Related]

  • 2. AP-1 inhibitory peptides attenuate in vitro cortical neuronal cell death induced by kainic acid.
    Meade AJ, Meloni BP, Mastaglia FL, Watt PM, Knuckey NW.
    Brain Res; 2010 Nov 11; 1360():8-16. PubMed ID: 20833150
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties.
    Meloni BP, Milani D, Edwards AB, Anderton RS, O'Hare Doig RL, Fitzgerald M, Palmer TN, Knuckey NW.
    Pharmacol Ther; 2015 Sep 11; 153():36-54. PubMed ID: 26048328
    [Abstract] [Full Text] [Related]

  • 4. AP-1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures.
    Meade AJ, Meloni BP, Cross J, Bakker AJ, Fear MW, Mastaglia FL, Watt PM, Knuckey NW.
    J Neurochem; 2010 Jan 11; 112(1):258-70. PubMed ID: 19878434
    [Abstract] [Full Text] [Related]

  • 5. Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model.
    Edwards AB, Anderton RS, Knuckey NW, Meloni BP.
    Mol Cell Biochem; 2017 Feb 11; 426(1-2):75-85. PubMed ID: 27844251
    [Abstract] [Full Text] [Related]

  • 6. Poly-arginine and arginine-rich peptides are neuroprotective in stroke models.
    Meloni BP, Brookes LM, Clark VW, Cross JL, Edwards AB, Anderton RS, Hopkins RM, Hoffmann K, Knuckey NW.
    J Cereb Blood Flow Metab; 2015 Jun 11; 35(6):993-1004. PubMed ID: 25669902
    [Abstract] [Full Text] [Related]

  • 7. Excitotoxic neuroprotection and vulnerability with CaMKII inhibition.
    Ashpole NM, Hudmon A.
    Mol Cell Neurosci; 2011 Apr 11; 46(4):720-30. PubMed ID: 21316454
    [Abstract] [Full Text] [Related]

  • 8. Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity.
    MacDougall G, Anderton RS, Mastaglia FL, Knuckey NW, Meloni BP.
    Mol Brain; 2019 Jul 17; 12(1):66. PubMed ID: 31315638
    [Abstract] [Full Text] [Related]

  • 9. Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.
    Meloni BP, Milani D, Cross JL, Clark VW, Edwards AB, Anderton RS, Blacker DJ, Knuckey NW.
    Neuromolecular Med; 2017 Sep 17; 19(2-3):271-285. PubMed ID: 28523591
    [Abstract] [Full Text] [Related]

  • 10. Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.
    Brooks N, Esparon S, Pouniotis D, Pietersz GA.
    Molecules; 2015 Aug 03; 20(8):14033-50. PubMed ID: 26247926
    [Abstract] [Full Text] [Related]

  • 11. Exploring the role of MKK7 in excitotoxicity and cerebral ischemia: a novel pharmacological strategy against brain injury.
    Vercelli A, Biggi S, Sclip A, Repetto IE, Cimini S, Falleroni F, Tomasi S, Monti R, Tonna N, Morelli F, Grande V, Stravalaci M, Biasini E, Marin O, Bianco F, di Marino D, Borsello T.
    Cell Death Dis; 2015 Aug 13; 6(8):e1854. PubMed ID: 26270349
    [Abstract] [Full Text] [Related]

  • 12. Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers.
    Ross MF, Filipovska A, Smith RA, Gait MJ, Murphy MP.
    Biochem J; 2004 Nov 01; 383(Pt. 3):457-68. PubMed ID: 15270716
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure.
    Bahnsen JS, Franzyk H, Sandberg-Schaal A, Nielsen HM.
    Biochim Biophys Acta; 2013 Feb 01; 1828(2):223-32. PubMed ID: 23085001
    [Abstract] [Full Text] [Related]

  • 14. Unconjugated TAT carrier peptide protects against excitotoxicity.
    Vaslin A, Rummel C, Clarke PG.
    Neurotox Res; 2009 Feb 01; 15(2):123-6. PubMed ID: 19384574
    [Abstract] [Full Text] [Related]

  • 15. Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.
    Gamir-Morralla A, López-Menéndez C, Ayuso-Dolado S, Tejeda GS, Montaner J, Rosell A, Iglesias T, Díaz-Guerra M.
    Cell Death Dis; 2015 Oct 22; 6(10):e1939. PubMed ID: 26492372
    [Abstract] [Full Text] [Related]

  • 16. Peptide-glycosaminoglycan cluster formation involving cell penetrating peptides.
    Rullo A, Qian J, Nitz M.
    Biopolymers; 2011 Oct 22; 95(10):722-31. PubMed ID: 21538329
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotection against transient focal cerebral ischemia and oxygen-glucose deprivation by interference with GluR6-PSD95 protein interaction.
    Yu CZ, Li C, Pei DS, Zong YY, Shi Q, Wen XR, Guan QH, Hang D, Hou XY, Zhang GY.
    Neurochem Res; 2009 Nov 22; 34(11):2008-21. PubMed ID: 19449206
    [Abstract] [Full Text] [Related]

  • 18. Lack of neuroprotection of inhibitory peptides targeting Jun/JNK after transient focal cerebral ischemia in spontaneously hypertensive rats.
    Gow WR, Campbell K, Meade AJ, Watt PM, Milech N, Knuckey NW, Meloni BP.
    J Cereb Blood Flow Metab; 2011 Dec 22; 31(12):e1-8. PubMed ID: 21971350
    [Abstract] [Full Text] [Related]

  • 19. Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat.
    Edwards AB, Cross JL, Anderton RS, Knuckey NW, Meloni BP.
    Mol Brain; 2018 Feb 09; 11(1):8. PubMed ID: 29426351
    [Abstract] [Full Text] [Related]

  • 20. Cell-Permeable Peptide Targeting the Nrf2-Keap1 Interaction: A Potential Novel Therapy for Global Cerebral Ischemia.
    Tu J, Zhang X, Zhu Y, Dai Y, Li N, Yang F, Zhang Q, Brann DW, Wang R.
    J Neurosci; 2015 Nov 04; 35(44):14727-39. PubMed ID: 26538645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.